NEW YORK (GenomeWeb) — BGI Americas and Gencove announced on Wednesday that they have agreed to join their respective technologies into a single low-pass sequencing service.
The service will join BGI's DNBseq next-generation sequencing technology — which uses combinatorial probe-anchor synthesis, rolling circle replication linear amplification, and DNA nanoballs — with Gencove's ImputeSeq low-pass sequencing analysis pipeline.
Both BGI Americas — a unit of China's BGI — and Gencove will offer the new service in North and South America. Additional terms of the deal were not disclosed.
BGI has formed a number of alliances in recent months including ones with Maxwell Plus; Xing Technology; Johns Hopkins and Mount Sinai Hospital; and the Ethiopian Biotechnology Institute.
Since it was spun out of the New York Genome Center in mid-2017, Gencove has launched a program to sequence up to 300 samples at low coverage for free in order to show the utility of its genome sequencing technology. It also has formed research collaborations with the Broad Institute, the University of Michigan, and the Baker Institute's Systems Genomics Laboratory in Australia.